The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter
ARIAD Pharmaceuticals Inc (ARIA)

ARIAD Pharmaceuticals is an oncology company. Co. is engaged in development and commercialization of small-molecule drugs to treat cancer patients. Co. is commercializing or developing the following three products and product candidates: Iclusig® (ponatinib), for the treatment of certain patients with rare forms of leukemia; Brigatinib, a drug candidate, which it is developing for the treatment of certain patients with a form of non-small cell lung cancer; and AP32788, which is being developed for the treatment of non-small cell lung cancer and other solid tumors.

ARIA SEC Filing Email Alerts Service

Company Name:  ARIAD Pharmaceuticals Inc
Sector:  Biotechnology
Number of ETFs Holding ARIA:  27
Total Market Value Held by ETFs:  $117.38M
Total Market Capitalization:  $1.48B
% of Market Cap. Held by ETFs:  7.91%
July 31, 2016    3:23 AM Eastern

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Buy (2.80 out of 4)
33rd percentile
(ranked lower than approx. 67% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

ARIAD Pharmaceuticals Inc (ARIA) Page | The Online Investor | | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.